FAGRON (FAGR.BR) Financials
FAGR.BR Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 1.0 billion | 539.3 million |
| 2023-06-30 | 1.0 billion | 584.2 million |
| 2023-03-31 | ? | ? |
| 2022-12-31 | 971.0 million | 562.4 million |
FAGR.BR Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 53.2 million | -1.2 million |
| 2023-06-30 | 15.7 million | 1.2 million |
| 2023-03-31 | ? | ? |
| 2022-12-31 | 52.2 million | 720000 |
FAGR.BR Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 37.5 million |
| 2023-06-30 | 33.0 million |
| 2023-03-31 | 16.5 million |
| 2022-12-31 | 34.4 million |
FAGR.BR Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 133.0 million | - | 41.7 million |
| 2023-06-30 | 119.0 million | - | 41.0 million |
| 2023-03-31 | - | - | - |
| 2022-12-31 | 125.3 million | - | 43.2 million |
FAGR.BR Shares Outstanding
FAGR.BR Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 17.5 million | - | - | - |
| 2023-06-30 | 21.0 million | - | - | - |
| 2023-03-31 | 10.5 million | - | - | - |
| 2022-12-31 | 11.8 million | 2.3 million | - | - |
FAGR.BR Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 391.4 million | 312.3 million |
| 2023-06-30 | 371.6 million | 294.6 million |
| 2023-03-31 | - | - |
| 2022-12-31 | 355.3 million | 284.7 million |
FAGR.BR
Price: €17.76
Dividend Yield: 0.02%
Forward Dividend Yield: 1.41%
Payout Ratio: 26.88%
Dividend Per Share: 0.25 EUR
Earnings Per Share: 0.97 EUR
P/E Ratio: 18.28
Exchange: BRU
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 1.2 billion
Average Dividend Frequency: 1
Years Paying Dividends: 6
DGR3: 28.52%